Jaroslav Tóth

Dr. Jaroslav Tóth

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2003 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
AVAnna Volleková
Anna Volleková
DKDaniela Košt'álová
Daniela Košt'álová
VKViktor Kettmann
Viktor Kettmann
JTJaroslav Tóth
Jaroslav Tóth

15 November 2023 in PeerJ
Verified
Journal Article
Open access
PDF file
SCSzilvia Czigle
Szilvia Czigle
MNMilan Nagy
Milan Nagy
PMPřemysl Mladěnka
Přemysl Mladěnka
JTJaroslav Tóth
Jaroslav Tóth
TOThe Oemonom.
The Oemonom.
Unlike conventional drug substances, herbal medicines are composed of a complex of biologically active compounds. Therefore, the potential occurrence of herb-drug interactions is even more probable than for drug-drug interactions. Interactions can occur on both the pharmacokinetic and pharmacodynamic level. Herbal medicines may affect the resulting efficacy of the concomitantly used (synthetic) drugs, mainly on the pharmacokinetic level, by changing their absorption, distribution, metabolism, and excretion. Studies on the pharmacodynamic interactions of herbal medicines and conventional drugs are still very limited. This interaction level is related to the mechanism of action of different plant constituents. Herb-drug interactions can cause changes in drug levels and activities and lead to therapeutic failure and/or side effects (sometimes toxicities, even fatal). This review aims to provide a summary of recent information on the potential drug interactions involving commonly used herbal medicines that affect the central nervous system (Camellia, Valeriana, Ginkgo, Hypericum, Humulus, Cannabis) and conventional drugs. The survey databases were used to identify primary scientific publications, case reports, and secondary databases on interactions were used later on as well. Search keywords were based on plant names (botanical genera), officinal herbal drugs, herbal drug preparations, herbal drug extracts.

31 December 2000 in Planta Medica
Verified
Journal Article
Closed access
PDF file
DTDaniela Tekel'Ová
Daniela Tekel'Ová
MRMiroslav Repčák
Miroslav Repčák
EZErika Zemková
Erika Zemková
JTJaroslav Tóth
Jaroslav Tóth
Samples of Hyperici herba were obtained by harvesting Hypericum perforatum L. in different plant development stages. The relation of flower development phases in the drug's flower fraction was examined. The HPLC method was then employed for the analysis of the content of secondary metabolites in different flower ontogenesis phases. The content of dianthrones, derivatives of quercetin and hyperforin increased from the first bud phases (0.29 %, 0.80 %, and 2.47 %, respectively) to flowers just opened (1.04 %, 4.23 % and 6.60 %, respectively). The content of dianthrones and quercetin glycosides then decreased (in unripe fruits 0.11 % and 0.08 %, respectively), whereas the amounts of hyperforin increased to 8.07 % in fruits. The content of I3,II8-biapigenin increased from 0.21 % in small buds to 1.04 % in buds just before opening and has then decreased gradually to a value of 0.02 % in fruits. Rutin was not detected in the samples.

19 February 2002 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MČMarta Čerňáková
Marta Čerňáková
DKDaniela Košt'álová
Daniela Košt'álová
VKViktor Kettmann
Viktor Kettmann
MPMiriam Plodová
Miriam Plodová
JTJaroslav Tóth
Jaroslav Tóth
JDJán Dřímal
Ján Dřímal
As part of a study aimed at developing new pharmaceutical products from natural resources, the purpose of this research was twofold: (1) to fractionate crude extracts from the bark of Mahonia aquifolium and (2) to evaluate the strength of the antimutagenic activity of the separate components against one of the common direct-acting chemical mutagens. The antimutagenic potency was evaluated against acridine orange (AO) by using Euglena gracilis as an eukaryotic test model, based on the ability of the test compound/fraction to prevent the mutagen-induced damage of chloroplast DNA. It was found that the antimutagenicity of the crude Mahonia extract resides in both bis-benzylisoquinoline (BBI) and protoberberine alkaloid fractions but only the protoberberine derivatives, jatrorrhizine and berberine, showed significant concentration-dependent inhibitory effect against the AO-induced chloroplast mutagenesis of E. gracilis. Especially berberine elicited, at a very low dose, remarkable suppression of the AO-induced mutagenicity, its antimutagenic potency being almost three orders of magnitude higher when compared to its close analogue, jatrorrhizine. Possible mechanisms of the antimutagenic action are discussed in terms of recent literature data. While the potent antimutagenic activity of the protoberberines most likely results from the inhibition of DNA topoisomerase I, the actual mechanism(s) for the BBI alkaloids is hard to be identified. Taken together, the results indicate that berberine possesses promising antimutagenic/anticarcinogenic potential that is worth to be investigated further.

12 August 2019 in Molecules
Verified
Journal Article
Open access
PDF file
AKAntonios Koutsoulas
Antonios Koutsoulas
MČMartina Čarnecká
Martina Čarnecká
JSJiří Slanina
Jiří Slanina
JTJaroslav Tóth
Jaroslav Tóth
IPIva Slaninová, Ph.D
Iva Slaninová, Ph.D
The phenolic compounds of methanolic extracts of Salvia pomifera and Salvia fruticosa were identified by liquid chromatography tandem mass spectrometry. Carnosic acid and its metabolite carnosol were the most abundant terpene phenolic compounds of S. fruticosa, while they were completely absent in S. pomifera. The main terpene phenolic constituent of S. pomifera was 12-O-methylcarnosic acid and its mass/mass fragmentation pathway was explained. The detailed mechanism of carnosic acid oxidation to carnosol was suggested. The effects of Salvia extracts and/or carnosic acid, the main diterpene phenolic component of S. fruticosa, on the proliferation and cell cycle of two melanoma cell lines (A375, Mel JuSo) and human fibroblast cell line (HFF) were investigated by MTT assay, PI-exclusion assay and flow cytometry cell cycle analysis. Extract of S. fruticosa more efficiently than S. pomifera extract reduced the proliferation of the human melanoma cells. Carnosic acid showed the most significant effect. The first evidence that carnosic acid affects microtubule dynamics and arrests the cell cycle in the G2/M phase was provided. Collectively, our results demonstrate that these two Salvia species are plants of medicinal interest with perspective for further investigation. Carnosic acid could be the compound responsible for the biological activities of S. fruticosa extracts.

1 August 2002 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
EMEva Miadoková
Eva Miadoková
IMIrena Mašterová
Irena Mašterová
VVViera Vlčková
Viera Vlčková
VDViola Dúhová
Viola Dúhová
JTJaroslav Tóth
Jaroslav Tóth